Malignancy-Associated Rheumatic Syndromes

0 Views
Published
When cancer mimics autoimmune disease, early recognition can be life-saving.
In this in-depth video, Dr. Rezaian explains Malignancy-Associated Rheumatic Syndromes (MARS)—a group of paraneoplastic conditions where cancer presents with rheumatologic symptoms like arthritis, myositis, vasculitis, and scleroderma.

Learn how to spot red flags, interpret atypical lab results, and connect autoimmune signs to hidden malignancies.
We cover key clinical patterns, essential blood tests, imaging strategies, and treatment protocols including prednisone, methotrexate, IVIG, and cyclophosphamide.
Whether you’re a rheumatologist, oncologist, medical student, or informed patient, this video provides critical insights at the intersection of rheumatology and oncology.

???? Topics Covered:
• What is MARS?
• Pathophysiology and paraneoplastic mechanisms
• Clinical red flags and diagnosis
• Cancer-linked autoimmune syndromes
• Lab and imaging workup
• Treatment and follow-up protocols

???? Keywords:
malignancy-associated rheumatic syndromes, paraneoplastic arthritis, cancer and autoimmunity, dermatomyositis cancer, hypertrophic osteoarthropathy, RS3PE, anti-TIF1γ, rheumatology oncology, autoimmune cancer clues
Category
Oncology
Be the first to comment